发明名称 PHARMACEUTICALLY APPLICABLE NANOSOL AND PROCESS FOR PREPARING THE SAME
摘要 <p>PCT No. PCT/DE92/01010 Sec. 371 Date Oct. 25, 1994 Sec. 102(e) Date Oct. 25, 1994 PCT Filed Dec. 4, 1992 PCT Pub. No. WO93/10768 PCT Pub. Date Jun. 10, 1993Nanosols and process for preparing the same allow colloidally dispersed solutions of scarcely water-soluble active substances to be stabilized with gelatin or its derivatives, by partly or fully setting the iso-ionic point (IIP, equivalent to a neutral charge) between the gelatin and the surface charged active substance particles. In order to neutralize the charge of the system composed of active substance particles and gelatin, the surface charge of the particles is compensated by a corresponding opposite charge of the gelatin molecules. For that purpose, a determined charge in relation to the isoelectric point (IEP) and the pH value of the solution is set on the gelatin molecules. By stabilizing in this way the practically monodispersed state thus generated, the Ostwald maturation of the colloidal particles of scarcely soluble active substance is strongly reduced. A new form of pharmaceutical administration having new properties can thus be obtained with generally scarcely water-soluble inorganic and organic compounds, in particular medicaments with a problematic bioavailablity. Preferred medicaments are glibenclamide and 3-indolylacetic acid derivatives, such as indomethacin or acemetacin.</p>
申请公布号 EP0615445(B1) 申请公布日期 1996.05.15
申请号 EP19920924547 申请日期 1992.12.04
申请人 ALFATEC-PHARMA GMBH 发明人 WUNDERLICH, JENS-CHRISTIAN;SCHICK, URSULA;WERRY, JUERGEN;FREIDENREICH, JUERGEN
分类号 A61K9/16;A61K9/20;A61K9/24;A61K9/50;A61K9/51;A61K38/28;(IPC1-7):A61K9/51;A61K47/42;A61K9/10 主分类号 A61K9/16
代理机构 代理人
主权项
地址